Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2013
10/31/2013US20130289041 Quinoxaline compounds and uses thereof
10/31/2013US20130289027 Isoquinoline Compounds And Methods For Treating HIV
10/31/2013US20130289020 CXCR4 Receptor Antagonists
10/31/2013US20130289004 Anti-staphylococcal celecoxib derivatives
10/31/2013US20130289002 Gyrase and topoisomerase iv inhibitors
10/30/2013EP2657230A1 Amide derivative and use thereof
10/30/2013EP2657228A1 Pyrazole synthesis by the coupling of carboxylic acid derivatives and enamines
10/30/2013EP2657227A1 Novel substituted isoquinoline derivative
10/30/2013EP2655399A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
10/30/2013EP2655378A1 Compounds and their use as bace inhibitors
10/30/2013EP2655367A1 N-substituted azetidine derivatives
10/30/2013EP2655365A1 2-carboxamide-4-piperazinyl-benzofuran derivative
10/30/2013EP2655364A1 A process for the preparation of lapatinib and its ditosylate salt
10/30/2013EP2655363A2 Crystalline forms and processes for their preparation
10/30/2013EP2655362A1 Hepatitis c inhibitors and uses thereof
10/30/2013EP2655358A1 Oxindolopyrimidine as igf1r receptor inhibitors
10/30/2013EP2655331A1 Glucagon receptor modulators
10/30/2013EP2654425A2 Ectoparasiticidal active substance combinations
10/30/2013CN1989099B Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
10/30/2013CN103380508A Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element
10/30/2013CN103380133A Compounds and their use as BACE inhibitors
10/30/2013CN103380129A 2-carboxamide-4-piperazinyl-benzofuran derivative
10/30/2013CN103380128A Crystalline forms and processes for their preparation
10/30/2013CN103380122A Novel benzodioxole piperazine compounds
10/30/2013CN103380118A Tau成像探针 Tau imaging probe
10/30/2013CN103373991A Method for preparing piribedil in high-purity high-yield manner
10/30/2013CN103373990A Chromophore molecule containing triptycene rigid stereochemical structure, and synthetic method and application thereof
10/30/2013CN103373988A 1, 2, 4-Triazole and pyrazine ring-containing acylhydrazone derivatives, preparation method and applications
10/30/2013CN103373985A 杂环化合物及其用途 Heterocyclic compounds and their use
10/30/2013CN103373928A Compound for organic light-emitting diode, organic light-emitting diode including the same and flat panel display device
10/30/2013CN102276593B Heterocyclic ketene hydrazone compound and preparation method as well as tubercle bacillus resistant application
10/30/2013CN102239164B 2H-chromene compound and derivative thereof
10/30/2013CN102066360B Quinoline or isoquinoline substituted P2X7 antagonists
10/30/2013CN101679358B Pyrrole derivatives as p2y12 antagonists
10/30/2013CN101133010B Process and intermediate compounds useful in preparation of statins
10/29/2013US8569543 CCR9 inhibitors and methods of use thereof
10/29/2013US8569353 Pyrazole compound
10/29/2013US8569339 Soluble guanylate cyclase activators
10/29/2013US8569317 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
10/29/2013US8569312 Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
10/29/2013CA2606682C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
10/24/2013WO2013158952A1 Isoindolone derivatives
10/24/2013WO2013158422A1 Heterocyclic compounds for controlling invertebrate pests
10/24/2013WO2013157886A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/24/2013WO2013157540A1 Nitrogen-containing heterocyclic compound or salt thereof
10/24/2013WO2013157511A1 Arylaminopyrazole derivative
10/24/2013WO2013157495A1 Organic electroluminescence element and production method for organic electroluminescence element
10/24/2013WO2013156935A1 Process for the preparation of crystalline vilazodone hydrochloride
10/24/2013WO2013156608A1 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
10/24/2013WO2013156559A1 N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
10/24/2013WO2013156318A1 Substituted pesticidal pyrazole compounds
10/24/2013US20130281505 Pyrazol-4-yl carboxamide derivatives as microbiocides
10/24/2013US20130281490 Disubstituted Beta-lactones as Inhibitors of N-Acylethanolamine Acid Amidase (NAAA)
10/24/2013US20130281489 Quaternary ammonium compounds useful as muscarinic receptor antagonists
10/24/2013US20130281486 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous system diseases
10/24/2013US20130281476 Modulators of Muscarinic Receptors
10/24/2013US20130281475 Inhibitors of c-fms kinase
10/24/2013US20130281465 Pyrazole derivative
10/24/2013US20130281455 Phenylpyri(mi)dinylazoles
10/24/2013US20130281453 Anti-cancer serine hydrolase inhibitory carbamates
10/24/2013US20130281451 Indolin-2-one derivatives as protein kinase inhibitors
10/24/2013US20130281450 Isoindolone derivatives
10/24/2013US20130281430 Amino-Indolyl-Substituted Imidazolyl-Pyrimidines and Their Use as Medicaments
10/24/2013US20130281428 Pyridone Derivatives
10/24/2013US20130281415 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
10/24/2013US20130281398 Treatment of diseases by epigenetic regulation
10/24/2013US20130281392 Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
10/24/2013US20130281366 Heterocyclic compounds suitable for the treatment of dyslipidemia
10/23/2013EP2651930A1 Biarylamide inhibitors of leukotriene production
10/23/2013EP2651929A1 Novel benzofurane compounds
10/23/2013EP2651916A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
10/23/2013EP2651913A1 Indeno- fused ring compounds having photochromic properties
10/23/2013EP2651912A1 Photochromic compounds and compositions
10/23/2013EP2651901A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
10/23/2013EP2651890A1 Strigolactam derivatives and their use as plant growth regulators
10/23/2013EP2651888A1 New compounds for the treatment of neurodegenerative diseases
10/23/2013CN103370808A 有机电致发光装置 Organic electroluminescent device
10/23/2013CN103370312A 1,3-dioxan-5-one compounds
10/23/2013CN103360384A Synthetic method for key intermediate of HMG-CoA reductase inhibitor
10/23/2013CN103360375A Olmesartan medoxomil intermediate and preparation method thereof
10/23/2013CN103360374A Synthesis method of vilazodone and salt thereof
10/23/2013CN103360373A Synthesis method of vilazodone intermediate and salt thereof
10/23/2013CN103360372A Novel preparation method of difenoconazole
10/23/2013CN103360317A Dicyclo-substituted pyrazolone azo derivatives, as well as preparation method and use thereof
10/23/2013CN103356636A Theramutein调节剂 Theramutein moderator
10/23/2013CN102036957B Compound comprising phenyl pyridine units
10/23/2013CN101679298B Fused bicyclic heteroaryl derivatives
10/23/2013CN101657443B [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
10/22/2013US8563596 Enantiomerically pure compounds for the treatment of proliferative disorders
10/22/2013US8563593 Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
10/22/2013US8563584 Substituted enaminothiocarbonyl compounds
10/22/2013US8563569 Compositions and methods for inhibition of the JAK pathway
10/22/2013US8563566 Naphthyridine derivatives as potassium channel modulators
10/22/2013CA2619450C 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/22/2013CA2613047C Method of synthesis of azole-containing amino acids
10/17/2013WO2013154325A1 Novel organic electroluminescent compounds and organic electroluminescent device containing the same
10/17/2013WO2013154109A1 Novel 1-substituted indazole derivative
10/17/2013WO2013153492A2 Process for the preparation of vilazodone hydrochloride and its amorphous form
10/17/2013WO2013152683A1 Bicycle substituted pyrazoloneazo derivatives and preparation method and use thereof
10/17/2013WO2013152392A1 Viral polymerase inhibitors
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 694